Q2 2018 EPS Estimates for Monsanto (MON) Lifted by Jefferies Group
Monsanto (NYSE:MON) – Investment analysts at Jefferies Group lifted their Q2 2018 earnings estimates for Monsanto in a research report issued to clients and investors on Friday. Jefferies Group analyst L. Alexander now expects that the basic materials company will post earnings per share of $3.50 for the quarter, up from their prior estimate of $3.29. Jefferies Group currently has a “Hold” rating and a $128.00 price target on the stock. Jefferies Group also issued estimates for Monsanto’s FY2019 earnings at $7.00 EPS and FY2020 earnings at $7.30 EPS.
Monsanto (NYSE:MON) last issued its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). The company had revenue of $2.66 billion for the quarter, compared to analysts’ expectations of $2.77 billion. Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The firm’s revenue for the quarter was up .3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.21 earnings per share.
A number of other analysts have also issued reports on the stock. Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. Royal Bank of Canada reaffirmed a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Wednesday, November 15th. Macquarie lowered shares of Monsanto from an “outperform” rating to a “neutral” rating in a research note on Wednesday, October 4th. Wells Fargo & Co upped their price objective on shares of Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research note on Tuesday, October 10th. Finally, BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research note on Thursday, October 5th. Eleven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $126.40.
Shares of Monsanto (MON) traded down $0.51 on Monday, hitting $118.81. 945,286 shares of the stock were exchanged, compared to its average volume of 3,000,000. The stock has a market capitalization of $52,300.00, a price-to-earnings ratio of 21.96, a P/E/G ratio of 1.69 and a beta of 1.04. Monsanto has a 1 year low of $106.74 and a 1 year high of $122.79. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.28 and a quick ratio of 0.79.
Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of Monsanto by 2.6% during the second quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock valued at $3,636,697,000 after acquiring an additional 784,418 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Monsanto by 6.5% during the second quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock valued at $3,302,038,000 after acquiring an additional 1,705,439 shares in the last quarter. State Street Corp increased its holdings in shares of Monsanto by 0.6% during the second quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock valued at $2,399,965,000 after acquiring an additional 122,814 shares in the last quarter. Capital International Investors increased its holdings in shares of Monsanto by 10.3% during the third quarter. Capital International Investors now owns 9,344,430 shares of the basic materials company’s stock valued at $1,119,650,000 after acquiring an additional 872,377 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Monsanto by 0.7% during the second quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock valued at $839,519,000 after acquiring an additional 47,725 shares in the last quarter. 75.34% of the stock is owned by institutional investors and hedge funds.
In other Monsanto news, CFO Pierre Courduroux sold 4,320 shares of the stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the sale, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at $5,903,336. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Nicole M. Ringenberg sold 7,890 shares of the stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $122.25, for a total transaction of $964,552.50. Following the sale, the vice president now directly owns 38,600 shares of the company’s stock, valued at $4,718,850. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company’s stock.
The company also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 1.82%. The ex-dividend date is Thursday, January 4th. Monsanto’s payout ratio is 39.93%.
ILLEGAL ACTIVITY WARNING: “Q2 2018 EPS Estimates for Monsanto (MON) Lifted by Jefferies Group” was originally published by Daily Political and is the property of of Daily Political. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.dailypolitical.com/2018/01/10/q2-2018-eps-estimates-for-monsanto-mon-lifted-by-jefferies-group.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.